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Dr. Ann Goldman, M.D. became one of first physicians in the world to practice pediatric 
palliative care. She pioneered a holistic multidisciplinary pain and symptom management 
model with her development of the Symptom Care Team in the 1980s at the Great 
Ormond Street Hospital, London, England. During her clinical career, she worked to get 
pediatric palliative care recognized as a specialty by the College of Pediatrics, was a 
founder member of the children’s charity Together for Short Lives (formally ACT), 
mentored many of the current leaders in pediatric pain and palliative care, has edited and 
authored numerous research articles, texts, and book chapters. She is currently an  editor 
for the Oxford Textbook of Palliative Care for Children.  
 
Interview Abstract  
Dr. Ann Goldman begins the interview by identifying some early field experiences as an 
oncologist researcher and observing service gaps in clinical patient care that didn’t 
acknowledge the psychosocial needs of families with chronically ill children. As Dr. 
Goldman was attempting to find guidance to develop her idea of providing more holistic 
care, she was met with some unease by peers and a discouraging message from Dame 
Cicely Saunders to not pursue this notion.  
 
Undaunted and driven by her innate knowledge that this idea was right, Dr. Goldman 
then describes her experience of being demoted in hospital hierarchy to “invent a job,” 
where she could establish a pain and symptom management service for pediatric patients 
with palliative care elements. She describes that she developed her team model from 
influences in pediatric pain and the adult palliative care field.  
 
Dr. Goldman was met with several challenges to her pain and symptom service. For 
example, there were no training resources for her multidisciplinary team. She also noted 
the importance of the relationships she developed that allowed her to expand beyond the 
oncology department. 
 
Dr. Goldman describes one of her proudest achievements being her role in legislative and 
public advocacy to help bring about the recognition of pediatric palliative care as a 
specialty and to develop training materials for providers globally through her charity 
work Together for Short Lives.  
 
Dr. Goldman concludes the interview with her vision of pediatric palliative care 
expanding outside of resource rich countries and helping resource poor countries achieve 
a greater degree of accessibility and to reduce the gap between children who need 
palliative care and children who don’t receive it.  
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Glossary of Acronyms  
 
Abbreviation Definition  
ACT Association for Children with life-threatening and Terminal conditions 
NHS National Health Service 
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Bryan Sisk: Today is May 13th, 2019. I am Bryan Sisk, and I'm in St. Louis, 
Missouri interviewing Dr. Ann Goldman over the telephone for the 
Pediatric Palliative Care Oral History Project. Dr. Goldman is in 
the Lake District in the United Kingdom. Thank you, Dr. 
Goldman, for joining me today. To get us started, can you tell me 
when your mind turned toward pediatric palliative care as a career 
focus? 
 
Ann Goldman: I was doing pediatric oncology. I was involved in a research 
project which was looking at one of the early monoclonal 
antibodies called UJ13A.1 One of the things we were doing, having 
done some basic animal work, was radio labeling it and using it to 
try and target radioactivity to children with disseminated 
neuroblastoma. In the process of this clinical trial, I met quite a lot 
of families with children with very advanced neuroblastoma.  
 
Two things were happening I suppose, in my mind; one was an 
increasing awareness that lab research with nude mice was not 
going to be my forte in life, and that I wanted to get back to 
clinical medicine. The second thing came to me I suppose through 
working with these families, that although most pediatric 
oncologists tend to have a special interest in a particular tumor,  
nobody seemed to have a particular interest in the needs of the 
children whose disease was so advanced that curative treatment 
and second or third line treatment were not going to be helpful or 
available for them. As I was thinking about getting back to clinical 
work, it seemed to me that this was a group of children I could be 
very interested in working to help. I've always been interested in, I 
suppose, people with serious disease but also psychosocial 
problems. That seemed to be exactly what these children had. 
 
That was where my interest in palliative care arose, I suppose. 
There was no pediatric palliative care at all at that time, but there 
was adult palliative care. I had read stuff to do with Cicely 
Saunders and her setting up St. Christopher's, and I've read things 
like Elisabeth Kübler-Ross who was writing it around that time. 
That's where it began. 
 
Bryan Sisk: I see.  
 
Ann Goldman: Does that help you? 
                                                 
1 Goldman, A., Vivian, G., Gordon, I., Pritchard, J., Kemshead, J. (1984). Immunolocalization of 
neuroblastoma using radiolabeled monoclonal antibody UJ13A. The Journal of Pediatrics, 105(2), 252-
256. 
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Bryan Sisk: It does, absolutely. Clearly it was on the cutting edge. There wasn't 
really a lot of similar minds at that time. When did you start 
finding people that thought similarly about these things that you 
did? 
 
Ann Goldman: There really weren't many people around thinking about it. I talked 
to our oncologist and he thought it was an interesting idea. I talked 
to Cicely Saunders. She thought it was a terribly bad idea. She 
wasn't interested in children at all and didn't think it was necessary. 
We had in the hospital at that time a system that we called Shared 
Care. Children who came from quite wide geographical areas to 
Great Ormond Street Hospital for care there; children with 
malignancies of whatever type, their care was shared with local 
hospitals. One of the things about the shared care was that it didn't 
work brilliantly. Often when families went back home, they felt 
very isolated and on their own. Hospitals we shared care with and 
their family doctors often felt very at a loss because they hadn't 
seen many children with problems like this.  
 
I sort of invented a job and an idea that we would have a team. 
There was certainly one nurse on the ward who was very interested 
in the idea of being able to be an outreach team from the hospital 
to help improve shared care. Our idea was we would have a team 
with medical and nursing input that would work with all the 
families who came to the oncology and hematology departments, 
not just the dying children. We called ourselves the "Symptom 
Care Team." We would be able to help with symptom management 
during treatment, we'd be able to help and do outreach work with 
the families when they first went home and with their family 
doctors and with their shared care hospitals, and that we would 
also be able to do outreach work with families when the child was 
entering end of life care and terminal palliative care. 
 
 We had the idea, but we had no money. The oncologist who was 
sympathetic to the idea helped me find a small charity that would 
fund myself and two nurses to start setting up the team, which is 
what we did.  
[00:06:34] 
Bryan Sisk: How did your bosses and your colleagues, how did they view your 
decision to go down this untrodden path? 
 
Ann Goldman: Well, with a certain amount of anxiety and a certain amount of 
interest. I'm just thinking back now. It's quite a long time ago. 
When I stopped doing the research, the neuroblastoma UJ13A 
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stuff, I actually was out of work because I wanted to set this team 
up, but we didn't have the money. I went and I was a locum, a 
temporary doctor in general pediatrics for a year. Our health care 
system's different —It was like an attending consultant post, which 
is our senior level post. When we eventually found the money for 
me to go back to Great Ormond Street and set up the team, I didn't 
go back at the senior level. I went back down to being a junior, I 
think so they could keep an eye on me and make sure it was 
working with a good plan. I took a drop in status and salary in 
order to set the team going.  
  
I think people were anxious because they always looked after their 
own patients, and wanted to look after their own patients, which is 
one of the of the differences from when Cicely Saunders was 
setting things up and she had surgeons who just abandoned their 
patients. The pediatric oncologists didn't abandon their patients, 
but I was just trying to say to them that I thought a closer focus 
would improve things. They felt maybe they were being excluded 
or perhaps that what they were doing wasn't thought to be good 
enough. I think that was an anxiety for them. They wanted to be 
supervising fairly closely, I think, just to start with, which they did.  
 
Bryan Sisk: That's a tight rope to walk.  
 
Ann Goldman: It was okay. There were people I got on well with and have respect 
for. I think they appreciated what I was after as well. 
[00:09:15] 
Bryan Sisk: Do you think that most of your colleagues recognized the need and 
the gaps in the care the same way you did, or was there a 
difference? 
 
Ann Goldman: I don't think they had really thought about it in the same way. I 
think they thought they were doing a reasonably good job and 
hadn't really put together some of the things that we could learn 
from adult palliative care and the support that the families really 
wanted, if they wanted to be at home rather than in hospital.  
 
Bryan Sisk: How many— 
 
Ann Goldman: Most of them were not familiar with the sort of drugs that were 
beginning to be used in adult palliative care at that time. 
[00:10:04] 
Bryan Sisk: This was the early 80s then? 
 
Ann Goldman: No, I think it was '74, wasn't it? 
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Bryan Sisk: I'm sorry, when you were starting this work. 
 
Ann Goldman: I'm just trying to think. It'll be there in my CV. I suppose it was 
very early 80s.  
 
Bryan Sisk: We've talked about—  
 
Ann Goldman: It might have been 70s. It will be there in the docket somewhere. 
 
Bryan Sisk: Yeah, it's in front of me here. I'll dig through it after our call. 
 
Ann Goldman: If you look down the jobs it'll tell you. 
[00:10:44] 
Bryan Sisk: We've talked about how there are these gaps in the care and these 
challenges in the care, but how was the care most lacking at that 
time in the late 70s when you were starting to think through this 
stuff as you left the neuroblastoma lab? 
 
Ann Goldman: I think the big thing that was missing was support for families who 
wanted to be at home. Also, people weren't focusing their mind on 
symptoms and improving symptom management, rather most of 
their focus being on ways of curing leukemia or lymphoma or 
whatever. But if you weren't curing it, then they hadn't put much 
energy and focus into thinking about the support people would 
need in the way of pain management and other symptom 
management, and psychosocial support at home. 
[00:11:47] 
Bryan Sisk: How effectively was pain managed back then? 
 
Ann Goldman: I think it was managed very individually. There were people who 
were more confident in using stronger opioids in children, and 
other people who were less confident. There was certainly no 
standardized way of doing things. There was no use of 
subcutaneous opioids when I started, certainly in our department 
there hadn't been. I put up the first subcutaneous syringe driver  
 
Bryan Sisk: In terms of— 
 
Ann Goldman: It was bringing in some of the ideas from the people who had been 
exploring in adult palliative care, I think, and having more 
confidence and experience. 
[00:12:46] 
Bryan Sisk: What do you think was the barrier to that confidence? Was it worry 
about addiction? Was it fear of harms? What was the big barrier to 
more use of strong opioids? 
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Ann Goldman: Again, I think it varied enormously. I don't think all those barriers 
have gone yet. There are still plenty people who are very anxious 
about addiction and worried about respiratory depression and 
overdosing. People are different. Part of the challenge was to try 
and work with colleagues and work out what it was that was 
stopping them or what they were afraid of and challenging that in a 
sophisticated enough way for them to believe that you understood 
what was happening and were capable of looking after things. 
[00:13:48] 
Bryan Sisk: What about the psychosocial needs that we talked about? How 
effectively were those recognized and managed? 
 
Ann Goldman: I think in oncology there was quite a lot of recognition of the 
psychosocial needs of families. Most departments specializing in 
malignant diseases have psychologists who specialized with them. 
People like Barbara Sourkes who was doing it in Boston in those 
days. We had also people, competent people, who were helping 
families. I think the big change really, or one of the big things that 
we recognized fairly early on, was that this wasn't just oncology. 
That although adult palliative care was focused entirely on 
oncology, in pediatrics we wanted to focus on all children with 
life-threatening illnesses. I think the recognition of the needs of 
children with other diagnoses was much poorer than it was in 
oncology patients. 
[00:15:12] 
Bryan Sisk: Do you think that recognition of how broad the field of palliative 
care needed to be in pediatrics, do you think that started from the 
very foundations of pediatric palliative care, or do you think there 
was still outside of your group an oncology focus initially? 
 
Ann Goldman: I think we started very early on because the first children's hospice 
Helen House was starting at very much the same time that I was 
starting, Helen House was a tiny bit before. There was a 
recognition by the pediatrician who was the president of the 
college of pediatrics, Professor David Baum, of the importance of 
palliative care. He put together a committee, which I was part of, 
and a number of nurses—a multidisciplinary committee, of people 
who were interested in, showing interest in palliative care. We put 
together the idea of having what's now the charity Together for 
Short Lives, which when we first put it together it was ACT 
[Association for Children with life-threatening and Terminal 
conditions], which you must have come across. 
 
 As soon as we started to do that, we put the criteria that we felt 
were important for people, those four ACT categories of 
diagnoses, the sorts of children who would benefit and sorts of 
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families who would benefit from the input of palliative care. We 
did that very early on. I know when I was interviewed for my job, 
when I moved from being a junior in the oncology department to a 
member of staff in the hospital, one of the things I said already at 
that time, one of my aims, was to move out of the oncology 
department and into the rest of the hospital. For me, and I think for 
pediatric and palliative care in the UK, it's been a very clear 
recognition right along from the very beginning. 
[00:17:43] 
Bryan Sisk: The adult palliative care movement really ramped up in the 60s 
going to the 70s, and the U.S. and U.K. and was really wrapped up 
into this strong autonomy movement and a lot of other social 
unrest that drove it from the outside in, but then there were also 
practitioners from the inside out driving it. What do you think were 
the main drivers for pediatric palliative care? Was it societal? 
 
Ann Goldman: I'm not sure in the U.K. it was such a societal demand.  
 
Bryan Sisk: Okay. 
 
Ann Goldman: I think it came from practitioners outwards. I don't have any 
recollection of it being a sort of push from society. 
[00:18:28] 
Bryan Sisk: From the adult side it was primarily from physicians outward? 
 
Ann Goldman: Yeah, I would say so. I haven't read deeply about it, but my 
recollection at the time was that it was an awareness that came 
from clinicians. 
[00:18:47] 
Bryan Sisk: Is that the same thing that happened in pediatrics? 
 
Ann Goldman: I think so, yes. I think there were families who wanted to care for 
their child at home when it was not a very common thing to do and 
who tried very hard to do so. I think it was working with those 
families that alerted clinicians like me to realize that they needed 
more support, and that it wasn't being done well. I don't think it 
was parents demanding it at all, or society demanding it.  
[00:19:32] 
Bryan Sisk: Do you think society even recognized there was a need before 
clinicians started raising awareness? 
 
Ann Goldman: I don't think they did. 
[00:19:52] 
Bryan Sisk: I wanted to go back. You had mentioned Cicely Saunders and how 
she was not a big fan of specifically pediatric palliative care as 
opposed to adults. Can you tell me a little more about that? 
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Ann Goldman: I don't think there's a lot more to tell. I went to see her and I said I 
was thinking about trying to develop more focus on palliative care 
and pediatrics. She said, "Oh well, there aren't really enough 
children with malignant diseases and I'm not sure that it's 
necessary," and "off you go," really. I think later she appreciated 
that we'd done a reasonable job and could see that it was a little bit 
different from adult palliative care, but she was never very 
interested in it.  
[00:20:53] 
Bryan Sisk: I've noticed from talking with some people who are in pediatrics 
and some people who are in adult, there seems to be a bit of a 
divide still about should it be palliative care with a continuum from 
children to adults, or should it be individual unique specialties that 
have unique skillsets that somewhat overlap? Is that a tension that 
you still notice in the field? 
 
Ann Goldman: Yeah, I think that's probably true. People don't get excited in 
cardiology and expect there to be one field and a continuum. There 
are pediatric oncologists and there are adult. There are pediatric 
cardiologists and adult cardiologists and nobody objects to that. 
Everybody recognizes that the picture is different and you need 
people who can focus on the needs of the different ages. 
Everybody I think is aware that there is a continuum where 
children become adults, but that doesn't mean you don't need 
people who can focus on different things. 
[00:22:10] 
Bryan Sisk: For you, what were the biggest challenges once the supportive care 
team was launched? What were your biggest challenges in your 
early career moving that forward? 
 
Ann Goldman: I think the need to spread out from oncology and help pediatricians 
and Great Ormond Street, which is a quaternary referral center. 
There's no child in there who comes in with straightforward 
illnesses; every child has got some sort of complex serious disease. 
There was lots of need for palliative care. I think it was trying to 
begin to move out of just oncology and help other people. That 
was one of the big challenges, really. Then of course there was just 
me. There was no training program, there were no junior staff, 
there was no training for the nurses particularly. It was beginning 
to get it recognized as a field and by the College of Pediatrics, by 
the nursing colleges, so that we could develop this into a specialty. 
[00:23:40] 
Bryan Sisk: When did it become an official specialty? 
 
Ann Goldman: Oh gosh, I can't remember. I can't remember. It took a while. Must 
have taken 15 years I should think. Ten years maybe. I don't know. 
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Bryan Sisk: Were you involved in that process of moving it towards a 
specialty? 
 
Ann Goldman: Oh yes. There was only me. For many years I was the only doctor 
doing it. I was involved in all of it. 
 
Bryan Sisk: How did you advocate? 
 
Ann Goldman: By going to college meetings, presenting papers, and by making a 
noise with the right people in the right places. 
[00:24:35] 
Bryan Sisk: Then you talked about how the charitable funding was really 
instrumental in your initial startup. How has the role of funders 
played a role in this development of pediatric palliative care in the 
U.K.? 
 
Ann Goldman: I don't think I can really speak for the whole of the U.K. But most 
new developments have come through charitable funding. Then 
they become established and then they sort of get absorbed into the 
national health system eventually. That's what happened to us. 
[00:25:23] 
Bryan Sisk: Now it's all NHS [National Health Service] funded, or is it still a 
lot of charitable funding? 
 
Ann Goldman: The children's hospice is almost entirely charitably funded. 
Children's hospices in the U.K. are hospice buildings. We don't call 
it hospice care, we use the term palliative care and then buildings 
are the hospices. They're still very much charitably funded. 
[00:25:51] 
Bryan Sisk: As your team was developing, we talked a little bit about how your 
colleagues viewed the team. How are the pediatric patients and the 
families viewing you? 
 
Ann Goldman: When we introduced ourselves as the Symptom Care Team to 
newly diagnosed oncology patients and said that what we did was 
help with the transition to home and we would help with their 
shared care, but we never particularly stressed that we helped with 
palliative care. They seemed to cotton on. They understood very 
quickly that we also did that. Since we were doing useful things for 
them all the way through from the time of diagnosis, we got to 
know them and that meant the transition was relatively easy to 
make in the oncology department.  
 
In other places I think it depended really on what those patients 
and their other teams had talked about. Also, the views of the other 
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specialists who called us into work alongside them. If they felt that 
we were the Angels of Death or the Death Squad, then that 
transferred to how the patients looked at us and thought about us. 
We often were brought in at times of transition and times when 
people were finding it difficult, particularly at the beginning. We 
almost always found ourselves being invited in when there was a 
crisis. In a way, by being able to manage those crises and being 
able to develop rapport with the families and with the staff, that we 
became much more a part of the hospital system and recognized as 
valuable.  
[00:28:08] 
Bryan Sisk: When you were starting out, did you have pretty high confidence 
that this was going to resonate and stick, or did you have questions 
about whether pediatric palliative care was going to take root? 
 
Ann Goldman: I was quite sure it was needed. I didn't have any doubts, really. 
[00:28:30] 
Bryan Sisk: There were simultaneous things that were developing primarily in 
Western Europe, primarily U.K., and then shortly after you there 
was some things developing in the U.S. When did you start to see 
more and more people pop up that who were of similar mind that 
were doing similar work outside of your immediate zone? 
 
Ann Goldman: Outside of? I can't hear you. 
 
Bryan Sisk: Outside of your immediate area. When did you start hearing about 
people in the U.S. and people in different cultures? 
 
Ann Goldman: People came to me. People who were interested came to me. 
People like Stephen Liben, Gerri Frager, a lot of the early people 
who started setting things up came and spent time with me first. 
John Collins from Australia. I don't know, loads of people would 
come and spend time with the team. People from Scandinavia 
came, people from all over the show. 
[00:29:37] 
Bryan Sisk: There really are a lot of interesting parallels between you and 
Cicely Saunders. You started something and became the hub for 
people to come and branch out and make advancements in their 
own areas.  
 
Ann Goldman: I think that's right. I think as far as I know I was the first physician 
who did this exclusively and called it paediatric palliative care. 
Other physicians—I think there were quite a lot more nurses doing 
very closely related things, but I was the first physician. Other 
physicians followed or contacted me to find out what we were 
doing. 
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Bryan Sisk: We've also talked about how you learned to some extent from the 
adult hospice movement and palliative care movement to pick up 
some of the skills and start to learn them in pediatrics. Were there 
any ways that the adult movement negatively influenced or 
hindered the development of pediatric as a specialty? Pediatric 
palliative care. 
 
Ann Goldman: I don't think so. When I wanted to learn, because I didn't really 
know anybody in palliative care, I had to go to the adult 
movement. There was nowhere else to go to except Helen House, 
which was doing respite care rather than medical palliative care. I 
did go to St. Christopher's. Cicely Saunders was happy for me to 
go and be an observer there for a few weeks. I did the same with an 
adult home care team in the north of London who were very 
helpful and supportive. I went to the adult palliative care shelf in 
the bookshop and bought the books, and then I just got on with it. 
 
Bryan Sisk: Learn as you go. 
 
Ann Goldman: Yeah. [laughs] In a way it was very easy because there was 
nothing. Whatever you did was a slight improvement. Now people 
get very anxious that there's a right way to do things, and have they 
been trained enough, and have they got the right qualifications? In 
many ways I think it was easier.  
[00:32:08] 
Bryan Sisk: How do you think the child suffering back then in the late 70s, 
early 80s, how do you think suffering was understood by 
clinicians? Do you think there was a holistic view, or do you think 
it was more focusing on individual symptoms? 
 
Ann Goldman: I don't know. Suffering is not the word that I use a lot, and it's not a 
word that permeates into my ideal of doing palliative care 
somehow. I don't know. Very hospicey word somehow. I think 
clinicians were all doing the best they could for people, and very 
often did think holistically and did try and work with families. I 
don't think people were ever being neglectful.  
[00:33:18] 
Bryan Sisk: Another interesting thing historically is from a similar recognition 
of children with severe symptoms, a lot times in life threatening or 
life shortening illness, it spawned your work in the pediatric 
palliative care world, and it also seems to have spawned this 
pediatric pain medicine field. Towards the beginning it seemed like 
you were really straddling both of those worlds, but now it seems 
like they have become very discreet entities. Do you have any 
insights into how that developed? 
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Ann Goldman: I think that pediatric pain medicine began with anesthetists in acute 
pain, didn't it? I learned a huge amount actually from becoming 
involved in pediatric pain circles. I think probably more than I 
learned from any other field. I regularly went to the big pain 
meetings with people like Chuck Berde and Neil Schechter. The 
whole group of them—Maria Fitzgerald. The level of 
sophistication of science they had was greater than the case-history 
presenting we were still doing in palliative care. 
[00:34:57] 
Bryan Sisk: The acute pain services, did they end up consulting on similar 
patients as your Symptom Care Team did, or did you take over 
most of that pain management? 
 
Ann Goldman: I can only speak for the hospital I was in. The anesthetists tended 
to be managing the post-operative pain and the intensivists were 
managing the pain in the intensive care unit, and we were doing 
other things around the hospital. I worked very closely in the end 
with one of my anesthetic colleagues and we set up a chronic pain 
clinic together, which was nothing really to do with palliative care, 
it was symptom management of pain and it was psychology 
support. It was chronic pain problems, really. Not the palliative 
care. It was a sort of sideline that we had together. I think they 
merged into each other. By getting to know each other it meant I 
could access my anesthetic colleagues for palliative care problems 
that initially I hadn't done. They could use us for problems that 
have more psychological issues that they weren't quite so 
interested and used to dealing with. 
[00:36:39] 
Bryan Sisk: We had talked a little bit about your role in developing ACT. 
Could you tell me, what are the biggest accomplishments and 
biggest wins that ACT had? Also, you said that it turned into 
Together for Short Lives, isn't that correct? 
 
Ann Goldman: Yes because originally ACT was a broad overview on all children 
with life threatening illnesses. Then there was a separate 
organization that was the Children's Hospice Association. 
Eventually we merged the two and called it Together for Short 
Lives. I think it's quite a powerful advocacy group, really, speaking 
for and working for all children and families with palliative care 
and being available to both professionals and to children and 
families. They've done lots of valuable things I think over the 
years. Practical things, care pathways, run conferences, brought 
together multidisciplinary colleagues. I think advocacy is probably 
the single thing that nobody else was doing that they had done and 
raised the whole profile of palliative care in pediatrics.  
Interviewer:  Bryan Sisk  May 13, 2019 





Bryan Sisk: Was that advocacy to the public? Advocacy to legislature? 
 
Ann Goldman: Sorry? I can't hear you. 
[00:38:38] 
Bryan Sisk: I'm sorry. Was that advocating to the public, or advocating to the 
government? What type of advocating were you doing? 
 
Ann Goldman: To the government, particularly, but also to the public in general. 
[00:38:54] 
Bryan Sisk: When you look over your career, what do you think have been the 
biggest changes from when you were starting to where we are now 
in the care for these children with this life threatening, life 
shortening illnesses? 
 
Ann Goldman: There are huge numbers of people doing it now. I think that's far 
and away the biggest change. That it is recognized as a need and a 
special interest in medicine, in nursing, in psychology, with special 
skills and knowledge. That we train people. 
[00:39:40] 
Bryan Sisk: What do you think are the biggest challenges that remain, 
currently? 
 
Ann Goldman: Let me think. I think the group of patients who are much more 
difficult to manage are the non-oncology patients. I think that they 
still have a lot of complex needs. I think we've got better at 
managing pain. Not perfect by any means, but I think a lot of the 
other symptoms, particularly children with neurodevelopmental 
problems have. I think there's a lot of scope for improving that. 
People who are involved in research and palliative care I think 
would be fairly unanimous in saying that the level of research that 
we do is still fairly basic, really, and that we could be a lot more 
sophisticated and that would improve the way we care for people. I 
don't know, what else? 
[00:41:12] 
Bryan Sisk: What do you think are the strongest things in the field right now? 
 
Ann Goldman: I'm not actually clinically practicing anymore and haven't really 
done for about ten years. I'm not sure. I'll tell you what actually the 
biggest need in the field is to move out of the well-resourced 
countries into the poorly resourced countries. That is far and away 
the biggest need because there are huge numbers of children with 
all sorts of illnesses and could benefit across the world. If you look 
at the WHO [World Health Organization] figures, they're very 
clear about that, aren't they? They say that 90 percent or more than 
90 percent of the children who could benefit from palliative care 
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are not getting it. There are loads of countries that still won't really 
allow anybody to have opioids. There's a lot of scope in the rest of 
the world. That's answering the question before last. I can't 
remember what the most recent question was. 
[00:42:35] 
Bryan Sisk: What do you think is the strongest area of the field of palliative 
care? 
 
Ann Goldman: I think just that it's there and that we're trying to get out into the 
rest of the world and the rest of the illnesses. That it's 
multidisciplinary and team-working, which again is something that 
so often medicine is not very good at, but it's very fundamental to 
palliative care. I think in many ways a lot of what we do is just 
very good clinical care. Some of it is quite specialized, but a lot of 
it is good holistic clinical care. We can be seen and I would hope 
that we would act as a beacon to other clinical medicine to go back 
to that concept of good holistic clinical care.  
[00:44:00] 
Bryan Sisk: Well actually, I'd love for you to just dream aloud, if budget and 
politics and all of the other potential obstacles, if they were not an 
issue, what would you want care for these children to look like in 
another ten years? 
 
Ann Goldman: I think I'd want it to be much more widespread, like I say, globally. 
I think we would have to train a lot more people, we would have to 
make opioids available to a lot more people. It should be that it's 
not something that is available to just one or two people, but to 
anybody, and it's coordinated and organized for them. 
[00:44:56] 
Bryan Sisk: Absolutely. Those are all the questions that I had, but do you think 
there’s any areas of this history that I've missed in our 
conversation? 
 
Ann Goldman: I don't know. Nothing that's leaping out at me. 
 
Bryan Sisk: Wonderful.  
 
[End of Audio] 
 
